Skip to content

Lumbar Plexus Catheter Versus Femoral Nerve Catheter for Postoperative Pain After Anterior Cruciate Ligament (ACL) Repair

Lumbar Plexus Catheter Versus Femoral Nerve Catheter Versus Single-shot Femoral Block for Postoperative Pain Control After Anterior Cruciate Ligament Reconstruction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01068275
Enrollment
114
Registered
2010-02-12
Start date
2010-04-30
Completion date
2012-09-30
Last updated
2010-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

anterior cruciate ligament, pain, postoperative, peripheral nerve catheter, nerve block, Children undergoing anterior cruciate ligament repair

Brief summary

Randomized trial comparing lumbar plexus catheter versus femoral nerve catheter (single-shot femoral block as control group) for postoperative pain control after anterior cruciate ligament repair in children (age 11-21). Primary outcome is pain scores for the first 72 hours. Secondary outcomes include opioid consumption, incidence of opioid side effects and quality of recovery (previously validated scale). Our hypothesis is that lumbar plexus catheter will provide superior pain control and overall quality of recovery compared to femoral nerve catheters.

Interventions

lumbar plexus catheter with 0.2% ropivacaine at 0.15 ml/kg/hr (max 10 ml/hr)

femoral nerve catheter with 0.2% ropivacaine at 0.15 ml/kg/hr (max 10 ml/hr)

PROCEDUREsingle-shot femoral block

single-shot femoral block with 0.2% ropivacaine 0.3 ml/kg (max 20 ml)

Sponsors

Seattle Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
11 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* ASA physical status 1-2 * Age 11-21 * Undergoing anterior cruciate ligament repair

Exclusion criteria

* Patient refusal * Coagulopathy * Systemic infection or infection at needle insertion site * Allergy to ropivacaine or opioids * Taking chronic opioids * Unavailable by phone

Design outcomes

Primary

MeasureTime frame
Postoperative pain scores72 hours

Secondary

MeasureTime frame
Quality of recovery72 hours
Opioid consumption72 hours
Opioid side effects72 hours

Countries

United States

Contacts

Primary ContactMichelle Sadler-Greever, RN
michelle.sadler-greever@seattlechildrens.org206-987-1937
Backup ContactFelicia M. Birch, MD
felicia.birch@seattlechildrens.org520-982-0665

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026